The strengths of this study encompass a thorough analysis that consolidates data from numerous research efforts, offering a wide-ranging assessment of S100 proteins and interleukins (IL-6, IL-10) across different stages of COVID-19 severity, thereby delivering important insights into their clinical significance. This evidence concerns the gene IL6 and COVID-19.